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HEMOLYTIC ANEMIA AND LOW RED CELL ATP/dATP RATIO IN 8 6 GENET I c ADENOSINE DEAM I NASE DEFICIENCY. ~lchael S, Hershfleld.JPanne-&Richard-.
Duke U n l v e r s l t y Medical Center, Departments o f Medlclne and Ped l a t r lcs, Durham, NC, USA.
Marked depletion of ATP and hemolysls have been reported t o accompany dATP accumulatlon i n erythrocytes o f p a t l e n t s undergoing treatment w l t h t h e ADA i n h l b l t o r deoxycoformycln (dCF), but n o t I n p a t l e n t s wlth i n h e r i t e d ADA deflclency. t h e r a t l o of ATP:dATP was 0.46-0.67. W e have prevlously described a mechanism by whlch dATP accumulatlon can induce marked ATP catabol Ism (Bagnara and Hershf ield, PNAS 79:2637, 1982) . Thus, ADA def lclency, l lke pyruvate klnase deficiency and masslvely Increased erthrocyte ADA a c t l v l t y , may be an inborn e r r o r o f metabolism t h a t can lead t o hemolysls by causing ATP depletlon. However, I n most cases scine compensatory mechanism must operate t o prevent ATP depletion as marked as I n t h e p a t i e n t we have described. In recent years, several antioxidant activities of uric acid have been described (PNAS 78:6858, 1981; FEBS LETT. 174:147, 1984) . The high reactivity of urate with singlet oxygen, hydroxyl radicals and various organic peroxides suggest that there may be important biological functions associated with such scavenging activity. We now report that, in addition to the foregoing capacities, uric acid increases the stability of ascorbic acid in serum about five-fold. A striking feature of this effect is the absence of measurable urfc acid disappearnace despite the marked inhibition of ascorbic acld oxidation. Thus, the stabilizing effect appears distinct from previously described stochiometric scavenging functions. Uric acid prevents the oxidation of ascorbic acid by an as yet undefined mechanism which does not involve its extensive oxidation to allantoin or other products. This stabilizing effect may have important consequences for the conservation of ascorbic acid in human blood and other biological fluids. The evolutionary loss of the ability to synthesize ascorbic acid may have been accompanied by a complementary loss of uricase. The latter mutation would insure levels of uric acid sufficiently high to stabilize ascorbic acid, derived from dietary. sources, for utilization at intracellular sites. Mouse neuroblastoma cells, NB, have been grown in increasing concentrations of mycophenolic acid for greater than 80 passages. A mycophenolic acid resistant neuroblastoma cell line (NB-MyR) has been isolated which is 1000-fold more resistant to mycophenolic acid than NB cells Fifty percent growth inhibition was caused by 1.6 x 10-j M and 1.65 x M mycophenolic acid for NB and NB-MyR cells respectively. In crude cell lysates the apparant inhibition constant for mycophenolic acid with inosinate dehydrogenase was 6 x 10-8 M and 14 x M for NB and NB-MyR cells respectively. Thus the ki for mycophenolic acid was essentially unchanged. The specific activity of inosinate dehydrogenase was 4.9 f 1.4 and 26.6 f 2.5 nmole/min/mg protein for NB and NB-MyR cells respectively. The 5.4-fold increase of inosinate dehydrogenase activity in the NB-MyR line may account in part for the increased resistance to mycophenolic acid. Preliminary findings also suggest a 3-fold increase in guanylate synthetase activity for NB-MyR cells as compared to NB cells. Adenosine deaminase (ADA) has been shown by genetic and biochemical evidence to be essential for the development of the immune system. In order to study ADA gene structure, regulation and expression, we have isolated mouse cell lines which contain amplified copies of ADA genes. In some cell lines ADA accounts for more than 75% of the soluble protein, representing an increase of 11,400 fold over parental cells. A cDNA library was constructed in pBR322 using an amplified cell line. Functional mouse ADA cDNA clones were isolated by genetic complementation of ADA-deficient E. coli. Analysis of plasmids containing functional ADA cDNA sequences suggested that ADA expression resulted mainly from 8-lactamase/ADA fusion proteins. The nucleotide sequence of a 1.65 kb insert was determined and found to contain a 1.056 kb open-reading frame (ORF). When this ORF was inserted into a bacterial expression vector, only a single band of murine ADA was detected upon starch gel analysis. This ORF was placed in a mammalian expression vector and introduced into COS cells where a high level of authentic murine ADA was obtained. A variety of rodent cell lines have been transformed using this vector. Helper-free preparations of retroviruses have been prepared which are capable of transducing functional ADA cDNA into cultured mammalian cells. These retroviral vectors should allow us to introduce the gene into hematopoietic stem cells.
